APM
Aptorum Group Ltd Class ANASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$7.21M
P/E Ratio
—
EPS
$-0.19
Beta
-0.01
52W High
$4.47
52W Low
$0.65
50-Day MA
$0.86
200-Day MA
$1.33
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Aptorum Group Ltd Class A
Aptorum Group Limited, a pharmaceutical company, is dedicated to the discovery, development and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. The company is headquartered in London, the United Kingdom.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 5,250 |
| EBITDA | $-1.56M |
| Operating Margin | 0.00% |
| Return on Equity | -10.80% |
| Return on Assets | -6.52% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.84 |
| Price-to-Book | 0.33 |
| Price-to-Sales (TTM) | 7.75 |
| EV/Revenue | 12.58 |
| EV/EBITDA | -0.46 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $6.35M |
| Float | $4.46M |
| % Insiders | 16.41% |
| % Institutions | 2.43% |
Data last updated: 4/7/2026